BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23408900)

  • 21. Inactivation of TGF-β signaling and loss of PTEN cooperate to induce colon cancer in vivo.
    Yu M; Trobridge P; Wang Y; Kanngurn S; Morris SM; Knoblaugh S; Grady WM
    Oncogene; 2014 Mar; 33(12):1538-47. PubMed ID: 23604118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restoration of TGF-beta signalling reduces tumorigenicity in human lung cancer cells.
    Anumanthan G; Halder SK; Osada H; Takahashi T; Massion PP; Carbone DP; Datta PK
    Br J Cancer; 2005 Nov; 93(10):1157-67. PubMed ID: 16251876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concordant promoter methylation of transforming growth factor-beta receptor types I and II occurs early in esophageal squamous cell carcinoma.
    Dong Z; Guo W; Guo Y; Kuang G; Yang Z
    Am J Med Sci; 2012 May; 343(5):375-81. PubMed ID: 22314103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks.
    Cheng N; Bhowmick NA; Chytil A; Gorksa AE; Brown KA; Muraoka R; Arteaga CL; Neilson EG; Hayward SW; Moses HL
    Oncogene; 2005 Jul; 24(32):5053-68. PubMed ID: 15856015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of TGF-beta receptor types II and III in oral squamous cell carcinoma and oral carcinoma-associated fibroblasts.
    Meng W; Xia Q; Wu L; Chen S; He X; Zhang L; Gao Q; Zhou H
    BMC Cancer; 2011 Feb; 11():88. PubMed ID: 21352603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solar ultraviolet irradiation reduces collagen in photoaged human skin by blocking transforming growth factor-beta type II receptor/Smad signaling.
    Quan T; He T; Kang S; Voorhees JJ; Fisher GJ
    Am J Pathol; 2004 Sep; 165(3):741-51. PubMed ID: 15331399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cathepsin B is the driving force of esophageal cell invasion in a fibroblast-dependent manner.
    Andl CD; McCowan KM; Allison GL; Rustgi AK
    Neoplasia; 2010 Jun; 12(6):485-98. PubMed ID: 20563251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concerted loss of TGFβ-mediated proliferation control and E-cadherin disrupts epithelial homeostasis and causes oral squamous cell carcinoma.
    Andl T; Le Bras GF; Richards NF; Allison GL; Loomans HA; Washington MK; Revetta F; Lee RK; Taylor C; Moses HL; Andl CD
    Carcinogenesis; 2014 Nov; 35(11):2602-10. PubMed ID: 25233932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and secretion of TGF-beta isoforms and expression of TGF-beta-receptors I, II and III in normal and neoplastic human breast.
    Chakravarthy D; Green AR; Green VL; Kerin MJ; Speirs V
    Int J Oncol; 1999 Jul; 15(1):187-94. PubMed ID: 10375614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher stromal expression of transforming growth factor-beta type II receptors is associated with poorer prognosis breast tumors.
    Barlow J; Yandell D; Weaver D; Casey T; Plaut K
    Breast Cancer Res Treat; 2003 May; 79(2):149-59. PubMed ID: 12825850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct roles of transforming growth factor-β signaling and transforming growth factor-β receptor inhibitor SB431542 in the regulation of p21 expression.
    Koo BH; Kim Y; Je Cho Y; Kim DS
    Eur J Pharmacol; 2015 Oct; 764():413-423. PubMed ID: 26187313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylation silencing of TGF-β receptor type II is involved in malignant transformation of esophageal squamous cell carcinoma.
    Ma Y; He S; Gao A; Zhang Y; Zhu Q; Wang P; Yang B; Yin H; Li Y; Song J; Yue P; Li M; Zhang D; Liu Y; Wang X; Guo M; Jiao Y
    Clin Epigenetics; 2020 Feb; 12(1):25. PubMed ID: 32046777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors.
    Ohashi S; Natsuizaka M; Wong GS; Michaylira CZ; Grugan KD; Stairs DB; Kalabis J; Vega ME; Kalman RA; Nakagawa M; Klein-Szanto AJ; Herlyn M; Diehl JA; Rustgi AK; Nakagawa H
    Cancer Res; 2010 May; 70(10):4174-84. PubMed ID: 20424117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TGF-β modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment.
    Yeung TL; Leung CS; Wong KK; Samimi G; Thompson MS; Liu J; Zaid TM; Ghosh S; Birrer MJ; Mok SC
    Cancer Res; 2013 Aug; 73(16):5016-28. PubMed ID: 23824740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of transforming growth factor-β type II receptor prohibit epithelial-to-mesenchymal transition in lens epithelium.
    Zheng D; Song T; Zhongliu X; Wu M; Liang J; Liu Y
    Mol Vis; 2012; 18():1238-46. PubMed ID: 22665970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
    Yang F; Strand DW; Rowley DR
    Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.
    Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U
    Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TGF-β signaling in myeloid cells is required for tumor metastasis.
    Pang Y; Gara SK; Achyut BR; Li Z; Yan HH; Day CP; Weiss JM; Trinchieri G; Morris JC; Yang L
    Cancer Discov; 2013 Aug; 3(8):936-51. PubMed ID: 23661553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoimmune pancreatitis results from loss of TGFbeta signalling in S100A4-positive dendritic cells.
    Boomershine CS; Chamberlain A; Kendall P; Afshar-Sharif AR; Huang H; Washington MK; Lawson WE; Thomas JW; Blackwell TS; Bhowmick NA
    Gut; 2009 Sep; 58(9):1267-74. PubMed ID: 19625278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epithelial Hic-5/ARA55 expression contributes to prostate tumorigenesis and castrate responsiveness.
    Li X; Martinez-Ferrer M; Botta V; Uwamariya C; Banerjee J; Bhowmick NA
    Oncogene; 2011 Jan; 30(2):167-77. PubMed ID: 20818421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.